About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Brca2
breast cancer 2, early onset
MGI:109337
48 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
ApcMin/Apc+
Brca2tm1Mbn/Brca2+
B6.Cg-Brca2tm1Mbn ApcMin
abnormal adrenal gland morphology J:67445
abnormal mammary gland development J:67445
abnormal ovarian follicle morphology J:67445
abnormal ovarian folliculogenesis J:67445
abnormal vagina epithelium morphology J:67445
absent corpus luteum J:67445
absent mature ovarian follicles J:67445
absent nipple J:67445
normal growth/size/body region phenotype J:67445
increased incidence of induced tumors J:67445
increased incidence of tumors by chemical induction J:67445
increased mammary gland tumor incidence J:67445
ovary atrophy J:67445
normal reproductive system phenotype J:67445
uterus atrophy J:67445
Brca1tm1Arge/Brca1tm1Arge
Brca2tm1Arge/Brca2tm1Arge
involves: 129S/SvEv * C57BL/6
abnormal embryonic tissue morphology J:40594
embryonic lethality, complete penetrance J:40594
Brca2tm1Arge/Brca2tm1Arge
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S/SvEv * 129S2/SvPas * C57BL/6
abnormal embryonic tissue morphology J:40594
exencephaly J:40594
prenatal lethality J:40594
Brca2tm1Brn/Brca2+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
involves: 129P2/OlaHsd * FVB/N
increased mammary adenocarcinoma incidence J:73028
increased mammary gland tumor incidence J:73028
increased skin tumor incidence J:73028
increased tumor incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
involves: 129 * C57BL/6 * SJL
increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Ptch1tm1Mps/Ptch1+
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
involves: 129 * C57BL/6 * SJL
increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Tg(Krt18-EGFP,-TAg121)36Ysng/0
Trp53tm1Brn/Trp53tm2Tyj
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N
increased ovary tumor incidence J:189304
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
involves: 129P2/OlaHsd * FVB/N
increased mammary adenocarcinoma incidence J:73028
increased mammary gland tumor incidence J:73028
increased skin tumor incidence J:73028
increased tumor incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
abnormal prostate gland morphology J:161511
abnormal prostate gland physiology J:161511
increased prostate intraepithelial neoplasia incidence J:161511
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
involves: 129P2/OlaHsd * FVB/N
increased mammary adenocarcinoma incidence J:73028
increased mammary gland tumor incidence J:73028
increased skin tumor incidence J:73028
increased tumor incidence J:73028
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
abnormal prostate gland physiology J:161511
increased prostate intraepithelial neoplasia incidence J:161511
prostate gland hyperplasia J:161511
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Tyj/Trp53+
Tg(Nes-cre)1Kln/0
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
abnormal tumor morphology J:144617
increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
increased medulloblastoma incidence J:144617
Brca2tm1Brn/Brca2tm1Brn
Trp53bp1tm1Jc/Trp53bp1tm1Jc
Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd
chromosome breakage J:197442
Brca2tm1Brn/Brca2tm1Cam
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
increased pancreatic acinar cell carcinoma incidence J:166678
increased pancreatic ductal adenocarcinoma incidence J:166678
premature death J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
increased pancreatic ductal adenocarcinoma incidence J:166678
premature death J:166678
Brca2tm1Cam/Brca2+
Krastm4Tyj/Kras+
Trp53tm3Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
increased pancreatic ductal adenocarcinoma incidence J:166678
premature death J:166678
Brca2tm1Cam/Brca2tm1Brn
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
exocrine pancreatic insufficiency J:166678
increased pancreas apoptosis J:166678
increased pancreatic ductal adenocarcinoma incidence J:166678
premature death J:166678
Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
Trp53tm3Tyj/Trp53+
involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N
exocrine pancreatic insufficiency J:166678
increased malignant tumor incidence J:166678
increased sarcoma incidence J:166678
premature death J:166678
Brca2tm1Kamc/Brca2tm1Kamc
Swsap1em1Mjn/Swsap1em1Mjn
involves: 129P2/OlaHsd * C57BL/6J * CBA/J
abnormal chromosomal synapsis J:268570
arrest of male meiosis J:268570
decreased testis weight J:268570
Brca2tm1Kamc/Brca2tm1Kamc
Trp53tm1Tyj/Trp53+
involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6
decreased survivor rate J:109193
increased mammary gland tumor incidence J:109193
increased osteosarcoma incidence J:109193
increased stomach tumor incidence J:109193
Brca2tm1Mak/Brca2tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA
abnormal chromosome morphology J:79697
decreased cellular sensitivity to ionizing radiation J:79697
normal immune system phenotype J:79697
increased activated T cell number J:79697
increased lymphoma incidence J:79697
increased malignant tumor incidence J:79697
increased osteosarcoma incidence J:79697
increased tumor incidence J:79697

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory